Sign in to continue:

Sunday, July 26th, 2026

万向钱潮股份公司重大资产重组进展公告(2026年5月最新信息)

详细解读

交易概述

万向钱潮股份公司于2024年5月6日披露了《发行股份及支付现金购买资产并募集配套资金暨关联交易预案》。公司计划通过发行股份及支付现金方式,收购Wanxiang America Corporation持有的全部股权,并向不超过35名特定投资者发行股份募集配套资金。此次交易不仅构成关联交易,还预计构成重大资产重组,但不属于重组上市。

交易进展

2024年4月30日,万向钱潮与交易对方签署了附条件生效的《发行股份及支付现金购买资产协议》,并召开第十届董事会第四次会议,审议通过了相关议案。关联董事已回避表决,独立董事对交易事项发表了审查意见。

2024年11月6日,公司发布了交易进展公告,说明尚未发出召开股东大会通知。经协商,公司将继续推进交易,并将在交易进展时重新召开董事会审议相关事项,届时的董事会决议公告日将作为发行股份的定价基准日。

截至公告披露日,尽职调查、审计、评估等工作正在进行,交易方案仍在磋商中,正式交易文件尚未签署。公司承诺将严格按照法律法规履行决策审批和信息披露义务,在方案细化后及时更新公告。

重要提醒及风险提示

  • 此次交易尚需履行董事会、股东大会、深圳证券交易所审核及中国证监会注册等程序,能否获批及最终完成时间存在不确定性。
  • 相关信息以公司指定信息披露媒体发布的公告为准,建议投资者密切关注后续公告并理性投资。
  • 如交易顺利推进,将显著影响公司资产结构、业务布局及未来发展,或对公司股价造成重大影响。

对股东及投资者的影响

本次重大资产重组若顺利完成,将极大增强万向钱潮的国际化业务能力及资产规模,或带来业务协同效应,提升公司长期价值。由于交易涉及关联方、重大资产重组及配套融资,交易若有实质进展、获批或发生变化,均可能对公司股价产生显著影响,属高度价格敏感事项。

后续展望

  • 公司将严格履行信息披露义务,投资者需关注后续公告。
  • 交易方案细化及审批进度将成为公司股价波动的重要因素。

免责声明

本新闻仅供参考,不构成任何投资建议。重大资产重组事项存在诸多不确定性,投资者应以公司公告为准,注意投资风险。


Detailed English Summary for Investors

Key Highlights

  • Wanxiang Qianchao Co., Ltd. (000559) is advancing a major asset restructuring involving issuing shares and paying cash to acquire assets, as well as raising supporting funds.
  • The deal targets the acquisition of 100% equity in Wanxiang America Corporation, through share issuance and cash payment.
  • This transaction is expected to constitute both a related-party transaction and a major asset restructuring, but it does not qualify as a restructuring listing.
  • Diligence, auditing, and valuation processes are underway, with formal transaction documents yet to be signed.
  • The company cautions investors that multiple procedures—board and shareholder meetings, SZSE review, and CSRC registration—are still required, with uncertainties about approval and completion.

Detailed Analysis

Transaction Overview

On May 6, 2024, Wanxiang Qianchao announced its plan to acquire 100% of Wanxiang America Corporation via share issuance and cash payment, and to raise supporting funds from up to 35 specific investors. The transaction constitutes a related-party deal and is expected to be a major asset restructuring, but not a restructuring listing.

Progress Update

On April 30, 2024, the company signed a conditional asset purchase agreement and held its 10th board’s 4th meeting to approve related proposals. Related directors abstained from voting; independent directors issued opinions.

As of November 6, 2024, Wanxiang Qianchao released a progress announcement, stating that shareholder meeting notifications have not yet been issued. The company will proceed with the transaction and will reconvene the board to review related matters once progress is made; the board resolution date will serve as the pricing benchmark for share issuance.

As of this disclosure, due diligence, auditing, and valuation are ongoing, and the transaction plan is being further negotiated. Formal transaction documents have not yet been signed. The company commits to strict compliance with legal procedures and timely disclosure of updates.

Key Risks and Reminders

  • The transaction requires multiple approvals—board, shareholders, SZSE, and CSRC registration. Approval outcome and timing remain uncertain.
  • Information should be based on official company disclosures; investors are advised to monitor subsequent announcements and invest rationally.
  • If the transaction progresses, it could significantly impact the company’s asset structure, business profile, and future prospects, potentially affecting share price.

Implications for Shareholders and Investors

If successfully completed, this restructuring will significantly strengthen Wanxiang Qianchao’s international business and asset scale, potentially providing synergistic business benefits and long-term value enhancement. Given its nature as a related-party, major asset restructuring, and supporting fundraising event, any substantive progress, approval, or change may have a material effect on the company’s share price, making this a highly price-sensitive matter.

Outlook

  • The company will strictly fulfill disclosure obligations; investors should closely follow subsequent announcements.
  • Details of the transaction plan and approval progress will be key drivers of share price volatility.

Disclaimer

This news article is for reference only and does not constitute investment advice. The asset restructuring carries significant uncertainties; investors should rely on official company disclosures and be aware of investment risks.

View 万向钱潮 Historical chart here



云南罗平锌电2025年度不分红公告:净利润亏损及利润分配预案说明

云南罗平锌电股份有限公司2025年度利润分配预案公告详解 云南罗平锌电股份有限公司2025年度利润分配预案公告详解 ...

世嘉科技增持光彩芯辰6.94%股权并完成首期付款——股权转让最新进展公告

世嘉科技股份有限公司:关于光彩芯辰(浙江)科技有限公司股权转让协议进展公告 要点摘要 世嘉科技(证券代码:002796...

Xintiandi Pharmaceutical 2025 Annual Report Summary: Business Overview, Financial Data, and Shareholder Information

新天地药业股份有限公司2025年度报告详细解读 新天地药业股份有限公司2025年度报告详细解读 一、报告摘要与关键信...